Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Colorcon
AstraZeneca
Moodys
Harvard Business School

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

Litigation Details for ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-06-22
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Freda L. Wolfson
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties ENDO PHARMACEUTICALS INC.; HARRY LEE GILLAM; LUPIN ATLANTIS HOLDINGS SA; LUPIN INC.
Patents 7,229,636; 7,404,489; 7,879,349; 8,003,353; 8,940,714; 9,415,007
Attorneys CHARLES MICHAEL LIZZA; JAMES S. RICHTER; Michael Keenan Nutter; SARAH ANN SULLIVAN; SARAH WENXUAN WANG; WILLIAM C. BATON
Firms Latham & Watkins LLP; Saul Ewing Arnstein & Lehr LLP; Winston & Strawn LLP - Chicago; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 U.S. Patent No. 7,229,636, # 2 Exhibit B - U.S. Patent No. 7,404,489, # 3 Exhibit C - U.S. Patent No. …U.S. Patent No. 8,003,353, # 5 Exhibit E - U.S. Patent No. 8,940,714, # 6 Exhibit F - U.S. Patent No. … COMPLAINT for Patent Infringement against Lupin Atlantis Holdings SA ( Filing fee $ 400 receipt… 22 June 2018 3:18-cv-10952 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Dow
Mallinckrodt
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.